Creative Biolabs provides research-use protein-protein interaction studies to help researchers identify candidate binding motifs, map interaction regions, and prioritize follow-up confirmation through phage display-based screening. This service is designed for target discovery, receptor-ligand exploration, antibody or peptide binder studies, domain-level interaction analysis, and early mechanistic research.
Phage display is particularly useful when genotype and binding phenotype need to be linked throughout iterative selection. Enriched phage clones can reveal peptide motifs, protein fragments, or candidate binders associated with a target. Because enrichment alone does not establish a complete biological interaction, we report candidates with clear interpretation boundaries and recommend orthogonal assays when stronger biochemical or cellular evidence is required.
Researchers often need this service when conventional pairwise testing is too narrow, when the binding region is unknown, or when a broad candidate pool must be narrowed before focused biochemical or cellular confirmation. A phage display route can provide an efficient discovery layer before targeted follow-up assays are designed.
Screen peptide, cDNA, antibody-fragment, or custom libraries to identify target-enriched candidate sequences.
Explore which protein regions, domains, or short sequence elements may contribute to binding.
Prioritize clones, motifs, or fragments before downstream peptide, protein, or antibody studies.
Generate a data-supported candidate list for subsequent biochemical or cellular confirmation.
We design each project around target format, immobilization route, library choice, negative selection, panning stringency, enrichment tracking, sequencing strategy, and confirmation plan. Depending on the research question, the study can be aligned with focused routes such as phage display protein interaction mapping, novel PPI discovery, interaction domain mapping, or binding motif identification. The output is a candidate interaction or motif package, not a standalone final proof of cellular protein-protein interaction.
Discuss Your Interaction Study
We review target sequence, domain boundaries, purity, tags, buffer conditions, and expected binding context.
The library format is selected according to target type, interaction hypothesis, and required discovery depth.
Binding, washing, counter-selection, and elution conditions are planned to balance specificity and recovery.
Selection rounds enrich candidate binders under controlled and progressively optimized stringency.
Clones or pools are analyzed for motifs, redundancy, sequence quality, and enrichment patterns.
Candidate motifs, fragments, or interaction partners are ranked for follow-up confirmation.
| Input Type | Useful Details |
|---|---|
| Target Material | Protein, domain, peptide, cell preparation, tag, buffer, purity, and concentration if available. |
| Library Plan | Peptide, cDNA, antibody-fragment, scaffold, or custom-library preference. |
| Study Goal | Motif discovery, domain mapping, candidate binder selection, receptor-ligand exploration, or follow-up assay design. |
Creative Biolabs can help define the most practical route when the target is difficult to express, purify, or immobilize. For projects centered on extracellular targets, membrane-proximal proteins, or receptor-rich sample formats, our ECM and cell-surface interactome service may also be considered.
Ask About Target Input Options
Target format, library type, panning plan, control design, and stringency notes.
Clone or pool sequence information with enrichment, redundancy, and quality comments.
Prioritized candidates based on sequence patterns, enrichment behavior, and assay context.
Recommended orthogonal assays and clearly defined interpretation boundaries.
QC checkpoints include target integrity, immobilization suitability, negative-control behavior, enrichment pattern, clone redundancy, sequencing quality, and consistency between screening design and data interpretation. We avoid overstating discovery data and do not present a candidate as a confirmed biological interaction unless follow-up evidence supports that conclusion.
Projects can be customized by target format, immobilization chemistry, library type, counter-selection strategy, number of selection rounds, washing stringency, sequencing depth, motif analysis format, and follow-up confirmation options. Nonstandard targets can be reviewed before quotation so that feasibility, sample requirements, and reporting scope are defined before the study begins.
Q: What information is needed to start a PPI study?
A: We usually need the target protein or domain information, available material format, library preference if known, research goal, and any planned follow-up assay.
Q: Can phage display by itself confirm a cellular PPI?
A: Phage display can discover candidate motifs or binders. Cellular or biochemical confirmation is usually needed before a candidate is treated as a confirmed biological PPI.
Q: What library types can be used?
A: Depending on the goal, peptide, cDNA, antibody-fragment, scaffold, or custom libraries may be considered. We select the format based on target type and discovery depth.
Q: Can you study membrane-associated targets?
A: Some membrane-associated targets can be approached through purified domains, peptides, vesicles, or cell-based formats. Feasibility depends on target stability and presentation.
Q: What deliverables are included?
A: We typically provide study design notes, enriched sequences, motif or candidate ranking, QC observations, and recommendations for orthogonal confirmation.
Q: Can you support downstream confirmation?
A: Yes. We can discuss ELISA, SPR/BLI, pull-down, peptide synthesis, mutagenesis, or other research-use follow-up assays depending on the candidate and target.
Please kindly note that our services can only be used to support research purposes (Not for clinical use).
Creative Biolabs is a globally recognized phage company. Creative Biolabs is committed to providing researchers with the most reliable service and the most competitive price.
